Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of...
News
LifeMD to Participate in Three Investor Conferences During November
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services,...
Tria Federal Announces Acquisition of Softrams, Creating a New Federal Health Powerhouse
Combination creates scaled, vertically integrated provider of technology and advisory capabilities serving critical federal health and public safety missions Tria...
iCAD’s ProFound Detection Version 4.0 Gains FDA Clearance
Provides 22% Overall Improvement in Detecting Challenging and Aggressive Cancer Subtypes and Enables Clinicians to Incorporate a Prior Exam into...
Tempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma
BRISBANE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted...
Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
SOLANA BEACH, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on...
Actuate Announces FDA Rare Pediatric Disease Designation Granted to Elraglusib for Treatment of Ewing Sarcoma
Ewing Sarcoma is a Highly Metastatic Form of Sarcoma and the Second Most Prevalent Primary Malignant Tumor in Children and...
Rectify Pharma to Host Virtual R&D Event on RTY-694 for Primary Sclerosing Cholangitis and Other Hepatobiliary Diseases on November 21, 2024
CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company developing positive functional modulators (PFMs),...
CG Oncology Reports Third Quarter 2024 Financial Results and Provides Business Updates
- Late-Breaking Abstract on Results of Phase 3 BOND-003 Trial of Cretostimogene Monotherapy in BCG-Unresponsive NMIBC Accepted at the Society...
2024 Tsingke High-Impact Literature Compilation – Gene Synthesis
BEIJING, Nov. 12, 2024 /PRNewswire/ -- Tsingke has delivered high-quality biotechnology services and products to nearly 300,000 users globally. The number...
MintNeuro Secures £1M Investment to Advance Transformative Semiconductor Technology for Neural Implants
Latest capital raise will accelerate delivery of silicon roadmap to drive next-generation implantable devices for neurological applications LONDON, Nov. 12,...
Spencer Trask Venture Good Measures Acquired by NationsBenefits, Bringing Personalized Nutrition to Millions
GREENWICH, Conn., Nov. 11, 2024 /PRNewswire/ -- Spencer Trask & Co., an advanced technology development firm, announced today that its...
Bunkerhill Health AI Powers Cardiovascular Screening at Stamford Health
SAN FRANCISCO, Oct. 21, 2024 /PRNewswire/ -- Stamford Health's Heart & Vascular Institute has announced it will be the first in...
Perceptive eClinical Launches ClinPhone 5: A Ground-breaking new RTSM Platform Delivering a Leap in Clinical Development Technology
Platform developed in collaboration with CRScube, capitalizing on learnings from world-leading pharma and biotech companies NOTTINGHAM, England, Nov. 11, 2024 /PRNewswire/...
MyndTec Announces Exclusive License Agreement with Albany Medical College for AI-Based Spinal Cord Stimulation Technology
Mississauga, Ontario--(Newsfile Corp. - November 11, 2024) - MyndTec Inc (CSE: MYTC). ("MyndTec" or the "Company"), a medical technology company...
Sonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”) (OTCQX: SONX), a leading dental technology company and developer of the GentleWave® System, today...
LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints
Top-line results compared to baseline at six months: Median apnea-hypopnea index reduction of 66.2% Median oxygen desaturation index reduction of...
Laboratory Information Management System Market to Grow by USD 1.63 Billion from 2024-2028, Recent Developments Boost Growth, Report with AI-Powered Market Evolution – Technavio
NEW YORK, Nov. 11, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The global laboratory information...
MARPAI REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
Turnaround continues to gain traction TAMPA, Fla., Nov. 11, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology...
Healthcare Cloud Computing Market to Grow by USD 98.6 Billion from 2024-2028, as Integrated Services Drive Demand with AI-Powered Market Evolution – Technavio
NEW YORK, Nov. 11, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The global healthcare cloud...